Hyoseon Jeong

Ms. Hyoseon Jeong

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
HKHye-jin Kim
Hye-jin Kim
JHJunghee Hyun
Junghee Hyun
HJHyoseon Jeong
Hyoseon Jeong
YLYeon-Kyeng Lee
Yeon-Kyeng Lee
Background: Carbapenemase-producing Enterobacteriaceae (CPE) are known to be primarily responsible for the increasing spread of carbapenem-resistant Enterobacteriaceae and have therefore been targeted for preventing transmission and appropriate treatment. This study aimed to describe the clinical and epidemiological characteristics and risk factors of CPE infection in terms of acquisition and colonization. Methods: We examined patients’ hospital data, including active screening on patients’ admission and in intensive care units (ICUs). We identified risk factors for CPE acquisition by comparing the clinical and epidemiological data of CPE-positive patients between colonization and acquisition groups. Results: A total of 77 CPE patients were included (51 colonized and 26 acquired). The most frequent Enterobacteriaceae species was Klebsiella pneumoniae. Among CPE-colonized patients, 80.4% had a hospitalization history within 3 months. CPE acquisition was significantly associated with treatment in an ICU [adjusted odds ratio (aOR): 46.72, 95% confidence interval (CI): 5.08–430.09] and holding a gastrointestinal tube (aOR: 12.70, 95% CI: 2.61–61.84). Conclusions: CPE acquisition was significantly associated with ICU stay, open wounds, holding catheters or tubes, and antibiotic treatment. Active CPE screening should be implemented on admission and periodically for high-risk patients.

31 August 2023 in Osong Public Health and Research Perspectives
Verified
Journal Article
Open access
HJHyoseon Jeong
Hyoseon Jeong
JHJunghee Hyun
Junghee Hyun
YLYeon-Kyeng Lee
Yeon-Kyeng Lee
Objectives: We aimed to describe the epidemiological characteristics of carbapenemase-producing Enterobacteriaceae (CPE) outbreaks in healthcare settings in the Republic of Korea between 2017 and 2022.Methods: Under the national notifiable disease surveillance system, we obtained annual descriptive statistics regarding the isolated species, carbapenemase genotype, healthcare facility type, outbreak location and duration, and number of patients affected and recommended interventions. We used epidemiological investigation reports on CPE outbreaks reported to Korea Disease Control and Prevention Agency from June 2017 to September 2022.Results: Among the 168 reports analyzed, Klebsiella pneumoniae (85.1%) was the most frequently reported species, while K. pneumoniae carbapenemase (KPC, 82.7%) was the most common carbapenemase genotype. Both categories increased from 2017 to 2022 (p<0.01). General hospitals had the highest proportion (54.8%), while tertiary general hospitals demonstrated a decreasing trend (p<0.01). The largest proportion of outbreaks occurred exclusively in intensive care units (ICUs, 44.0%), and the frequency of concurrent outbreaks in ICUs and general wards increased over time (p<0.01). The median outbreak duration rose from 43.5 days before the coronavirus disease 2019 (COVID-19) pandemic (2017–2019) to 79.5 days during the pandemic (2020–2022) (p=0.01), and the median number of patients associated with each outbreak increased from 5.0 to 6.0 (p=0.03). Frequently recommended interventions included employee education (38.1%), and 3 or more measures were proposed for 45.2% of outbreaks.Conclusion: In the Republic of Korea, CPE outbreaks have been consistently dominated by K. pneumoniae and KPC. The size of these outbreaks increased during the COVID-19 pandemic. Our findings highlight the need for continuing efforts to control CPE outbreaks using a multimodal approach, while considering their epidemiology.

25 November 2025 in Public Health Weekly Report
Verified
Journal Article
Open access
PDF file
HJHyoseon Jeong
Hyoseon Jeong
영안영서 안
영서 안
승이승재 이
승재 이
정효선, 안영서, 이승재. Public Health Weekly Report 2025;18:2063-79. https://doi.org/10.56786/PHWR.2025.18.50.2

24 August 2026
Verified
Journal Article
Open access
PDF file
진오진아 오
진아 오
민이민혜 이
민혜 이
우심우리 심
우리 심
HJHyoseon Jeong
Hyoseon Jeong
상여상구 여
상구 여
종김종희 김
종희 김
오진아, 이민혜, 심우리, 정효선, 여상구, 김종희. Public Health Weekly Report 2026;19:27-42. https://doi.org/10.56786/PHWR.2026.19.36suppl.2